Liver‐related long‐term outcomes of thiazolidinedione use in persons with type 2 diabetes

BACKGROUND & AIMS: Studies have described prominent histologic improvement in patients with nonalcoholic steatohepatitis (NASH) using thiazolidinedione (TZD); however, these were all short term with moderate sample size, no liver‐related long‐term outcomes could be noted. METHODS: This retrospec...

Descripción completa

Detalles Bibliográficos
Autores principales: Yen, Fu‐Shun, Yang, Yu‐Cih, Hwu, Chii‐Min, Wei, James C.‐C., Huang, Yi‐Hsiang, Hou, Ming‐Chih, Hsu, Chih‐Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Metabolic & Toxic Liver Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7317545/
https://www.ncbi.nlm.nih.gov/pubmed/31960563
http://dx.doi.org/10.1111/liv.14385

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7317545/
https://www.ncbi.nlm.nih.gov/pubmed/31960563
http://dx.doi.org/10.1111/liv.14385

Ejemplares similares